Overview

Phytopathological Disease Diagnostics Market is estimated to register a CAGR of over 4% during the forecast period 2020 to 2027.

Increase in the prevalence of phtopathological diseases, growing developments in the diagnostic technologies for treating these diseases are some factors driving the phytopathological disease diagnostics market growth. The plant pathology sector has made some substantial developments by elucidating the principles of disease epidemics and this has resulted in improvements in the empirical understanding of disease dynamics. Furthermore, it has improved the accuracy of a disease outbreak or the necessity for real-time disease control and strategic solutions to disease-related issues. 
Molecular diagnostic methods based on PCR are being increasingly used for guiding the diagnosis of phytopathological diseases. Furthermore, rising prevalence of plant-related diseases along with the risen availability of genomic and genetic information, which has resulted in the rapid PCR incorporation in clinical laboratories. The high sensitivity, specificity and low requirement of samples has made molecular assays a regularised method for detecting pathogens during a disease outbreak. Such phytopathological disease diagnostics market trends shall propel the market growth.

Market Segmentation:

By Product
•    Kits
•    Accessories
•    Other Consumables     
By Test
•    PCR-Based Assays
•    Isothermal Amplification Assays
•    Serological Tests
•    Others     
By End User 
•    Academic and Research Institutes
•    Food Processing Laboratories
•    Others
By Region
•    North America
•    Europe
•    Asia-Pacific
•    Latin America
•    Middle East and Africa

The market is fragmented into product, test, end user and region. The product segment is categorised into kits, accessories and other consumables. The test segment is diversified into PCR-based assays, isothermal amplification assays, serological tests and others. The end user segment is classified into academic and research institutes, food processing laboratories and others.

Regional Analysis:

The North America region is predicted to dominate the market during the forecast period owing to rising research and development activities, a strong presence of key market players, systematic diagnostic laboratories and the high adoption of advanced assay technologies. Furthermore, there has been significant developments made in plant genomic and genetic engineering research in biotech industries present in the region. 

Competitive Landscape:                            

Some of the major market players are Abingdon Health, Agdia Inc., BIOREBA AG, Creative Diagnostics, LOEWE Biochemica GmBH, Norgen Biotek Corp., Qualiplante SAS, TwistDx Limited.

FutureWise Key Takeaways:

•    Growth prospects
•    SWOT analysis 
•    Key market trends 
•    Key data-points affecting market growth

Objectives of the Study:

•    To provide with an exhaustive analysis on the global phytopathological disease diagnostics market by product, by test, by end user and by region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
•    To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
       1.1 Objectives of the Study 
       1.2 Market Definition 
       1.3 Market Scope 
                1.3.1 Years Considered for the Study
                1.3.2 Market Covered
       1.4 Currency
       1.5 Limitations 
       1.6 Stakeholders     
2. Research Methodology 
        2.1 Research Data 
             2.1.1 Secondary Data
                      2.1.1.1 Key Data from Secondary Sources
             2.1.2 Primary Data
                         2.1.2.1 Key Data from Primary Sources
        2.2 Market Size Estimation 
        2.3 Market Breakdown and Data Triangulation 
        2.4 Assumptions for the Study  
3. Executive Summary
        3.1 Market Outlook
        3.2 Segment Outlook
        3.3 Competitive Insights
4. Market Variables, Trends & Scope
        4.1 Market Lineage Outlook
        4.2 Penetration and Growth Prospect Mapping
        4.3 Industry Value Chain Analysis
        4.4 Cost Analysis Breakdown
        4.5 Technology Overview
        4.6 Regulatory Framework on Country Level
             4.6.1 Reimbursement Framework    
             4.6.2 Standards and Compliances
5. Market Overview
        5.1 Market Dynamics
              5.1.1 Market Driver Analysis         
              5.1.2 Market Restraint Analysis         
              5.1.3 Industry Challenges                   
6. Market Analysis tools                       
        6.1 Industry Analysis - Porter’s
                     6.1.1 Supplier Power
                     6.1.2 Buyer Power
                     6.1.3 Substitution Threat
                     6.1.4 Threat from new entrants
                     6.1.5 Competitive Rivalry                 
        6.2 Pestel Analysis
                     6.2.1 Political Landscape
                     6.2.2 Environmental Landscape
                     6.2.3 Social landscape
                     6.2.4 Technology landscape
                     6.2.5 Legal Landscape
7. Phytopathological Disease Diagnostics Market, By Product Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
        7.1 Kits
        7.2 Accessories
        7.3 Other Consumables                         
8. Phytopathological Disease Diagnostics Market, By Test Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
        8.1 PCR-Based Assays
        8.2 Isothermal Amplification Assays
        8.3 Serological Tests
        8.4 Others         
9. Phytopathological Disease Diagnostics Market, By End User Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
         9.1 Academic and Research Institutes
         9.2 Food Processing Laboratories
         9.3 Others
10. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
         10.1. Introduction
         10.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019
                10.2.1. U.S.
                10.2.2. Canada
                10.2.3. Mexico 
                10.2.4. Rest of North America
         10.3 Market Size (USD Mn) Forecast for North America 2020-2027
11. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
         11.1. Introduction
         11.2. Regional Market Trends
         11.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019
                11.3.1. Brazil
                11.3.2. Venezuela
                11.3.3. Argentina
                11.3.4. Rest of Latin America
          11.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027
12. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
           12.1. Introduction
           12.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019
                12.2.1. Germany
                12.2.2. U.K
                12.2.3. France
                12.2.4. Italy
                12.2.5 Switzerland
                12.2.6. Spain
                12.2.7. Russia
                12.2.8. Poland
                12.2.9. Rest of Western Europe
           12.3 Market Size (US$ Mn) Forecast for Europe 2020-2027
13. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
           13.1 Introduction
           13.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019
                 13.2.1 Japan
                 13.2.2 China
                 13.2.3 Singapore
                 13.2.4 Korea         
                 13.2.5 India
                 13.2.6 Australia and New Zealand
                 13.2.7 ASEAN
                 13.2.8 Rest of Asia Pacific
           13.3 Market Size (US$ Mn) Forecast for Asia Pacific 2020-2027
14. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    14.1 Introduction
    14.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019
        14.2.1 UAE
        14.2.2 South Africa
        14.2.3 Egypt
        14.2.4 Saudi Arabia
        14.2.5 Rest of MEA
    14.3 Market Size (US$ Mn) Forecast for MEA 2020-2027
15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
    15.1 Abingdon Health
            15.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.1.2. Product Portfolio
            15.1.3. SWOT Analysis
            15.1.4. Financial Overview
            15.1.5. Strategic Overview
    15.2 Agdia Inc.
              15.2.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.2.2. Product Portfolio
              15.2.3. SWOT Analysis
              15.2.4. Financial Overview
              15.2.5. Strategic Overview
    15.3 BIOREBA AG
              15.3.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.3.2. Product Portfolio
              15.3.3. SWOT Analysis
              15.3.4. Financial Overview
              15.3.5. Strategic Overview
    15.4 Creative Diagnostics
             15.4.1. Company Overview (HQ, Business Segments, Employee Strength)
             15.4.2. Product Portfolio
             15.4.3. SWOT Analysis
             15.4.4. Financial Overview
             15.4.5. Strategic Overview
    15.5 LOEWE Biochemica GmBH
              15.5.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.5.2. Product Portfolio
              15.5.3. SWOT Analysis
              15.5.4. Financial Overview
              15.5.5. Strategic Overview
    15.6 Norgen Biotek Corp.
              15.6.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.6.2. Product Portfolio
              15.6.3. SWOT Analysis
              15.6.4. Financial Overview
              15.6.5. Strategic Overview
    15.7 Qualiplante SAS
             15.7.1. Company Overview (HQ, Business Segments, Employee Strength)
             15.7.2. Product Portfolio
             15.7.3. SWOT Analysis
             15.7.4. Financial Overview
             15.7.5. Strategic Overview
    15.8 TwistDx Limited
              15.8.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.8.2. Product Portfolio
              15.8.3. SWOT Analysis
              15.8.4. Financial Overview
              15.8.5. Strategic Overview    
16. Impact of COVID-19
      16.1. Positive influence on the healthcare industry
      16.2. The financial disruption of the manufacturing sector
      16.3. Impact of COVID-19 on emerging companies
      16.4. Significant mandates in the healthcare regulations initiated by administrations
      16.5. The overall economic slowdown of the developing and developed nations
17. Competitive Intelligence and Competitive Matrix
      17.1 Competitive Intelligence
      17.2 Competitive Matrix
18. Major Deals and Strategic Alliances Analysis
      18.1 Joint ventures
      18.2 Mergers and acquisitions              
      18.3 Licensing and partnerships
      18.4 Technology Collaborations
      18.5 Strategic Divestments
      18.6 Market Entry Strategies                        
19. Relevant Case Studies and Latest News Updates
20. Key Market Takeaway Points from the Market Analysts at Future Market Analytics

Tables

Figures